194 related articles for article (PubMed ID: 36706789)
1. Uterine-preserving treatments or hysterectomy reintervention after myomectomy or uterine artery embolisation: A retrospective cohort study of long-term outcomes.
Amoah A; Quinn SD
BJOG; 2023 Jun; 130(7):823-831. PubMed ID: 36706789
[TBL] [Abstract][Full Text] [Related]
2. Reintervention Rates After Myomectomy, Endometrial Ablation, and Uterine Artery Embolization for Patients with Uterine Fibroids.
Davis MR; Soliman AM; Castelli-Haley J; Snabes MC; Surrey ES
J Womens Health (Larchmt); 2018 Oct; 27(10):1204-1214. PubMed ID: 30085898
[TBL] [Abstract][Full Text] [Related]
3. Comparative Effectiveness of Uterine Leiomyoma Procedures Using a Large Insurance Claims Database.
Borah BJ; Yao X; Laughlin-Tommaso SK; Heien HC; Stewart EA
Obstet Gynecol; 2017 Nov; 130(5):1047-1056. PubMed ID: 29016510
[TBL] [Abstract][Full Text] [Related]
4. A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. The HOPEFUL study.
Hirst A; Dutton S; Wu O; Briggs A; Edwards C; Waldenmaier L; Maresh M; Nicholson A; McPherson K
Health Technol Assess; 2008 Mar; 12(5):1-248, iii. PubMed ID: 18331704
[TBL] [Abstract][Full Text] [Related]
5. Uterine artery embolisation or myomectomy for women with uterine fibroids wishing to avoid hysterectomy: a cost-utility analysis of the FEMME trial.
Rana D; Wu O; Cheed V; Middleton LJ; Moss J; Lumsden MA; McKinnon W; Daniels J; Sirkeci F; Manyonda I; Belli AM; McPherson K;
BJOG; 2021 Oct; 128(11):1793-1802. PubMed ID: 34053154
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Risk of Reintervention After Surgical Leiomyoma Treatment in an Integrated Health Care System.
Mitro SD; Xu F; Lee C; Zaritsky E; Waetjen LE; Wise LA; Hedderson MM
Obstet Gynecol; 2024 May; 143(5):619-626. PubMed ID: 38547478
[TBL] [Abstract][Full Text] [Related]
7. Uterine artery embolization for symptomatic uterine fibroids.
Gupta JK; Sinha A; Lumsden MA; Hickey M
Cochrane Database Syst Rev; 2014 Dec; (12):CD005073. PubMed ID: 25541260
[TBL] [Abstract][Full Text] [Related]
8. A Comparative Analysis of Health-Related Quality of Life 1 Year Following Myomectomy or Uterine Artery Embolization: Findings from the COMPARE-UF Registry.
Anchan RM; Wojdyla D; Bortoletto P; Terry K; Disler E; Milne A; Gargiulo A; Petrozza J; Brook O; Srouji S; Morton CC; Greenberg J; Wegienka G; Stewart EA; Nicholson WK; Thomas L; Venable S; Laughlin-Tommaso S; Diamond MP; Maxwell GL; Marsh EE; Myers ER; Vines AI; Wise LA; Wallace K; Jacoby VL; Spies JB
J Womens Health (Larchmt); 2023 Apr; 32(4):423-433. PubMed ID: 36637808
[No Abstract] [Full Text] [Related]
9. A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial.
McPherson K; Manyonda I; Lumsden MA; Belli AM; Moss J; Wu O; Middleton L; Daniels J
Trials; 2014 Nov; 15():468. PubMed ID: 25432688
[TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of uterine artery embolization (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): subanalysis of 5-year MRI findings.
Ananthakrishnan G; Murray L; Ritchie M; Murray G; Bryden F; Lassman S; Lumsden MA; Moss JG
Cardiovasc Intervent Radiol; 2013 Jun; 36(3):676-81. PubMed ID: 23070101
[TBL] [Abstract][Full Text] [Related]
11. Uterine artery embolization for symptomatic uterine fibroids.
Gupta JK; Sinha A; Lumsden MA; Hickey M
Cochrane Database Syst Rev; 2012 May; (5):CD005073. PubMed ID: 22592701
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy outcome after emergency uterine artery embolisation for management of intractable haemorrhage associated with laparoscopic-assisted myomectomy.
Takeda A; Koike W; Tsuge S; Shibata M; Shinone S; Nakamura H
J Obstet Gynaecol; 2020 Nov; 40(8):1111-1117. PubMed ID: 32027204
[TBL] [Abstract][Full Text] [Related]
13. Utilization of Endovascular and Surgical Treatments for Symptomatic Uterine Leiomyomas: A Population Health Perspective.
Wang C; Kuban JD; Lee SR; Yevich S; Metwalli Z; McCarthy CJ; Sheth SA; Sheth RA
J Vasc Interv Radiol; 2020 Oct; 31(10):1552-1559.e1. PubMed ID: 32917502
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids.
Wallace K; Zhang S; Thomas L; Stewart EA; Nicholson WK; Wegienka GR; Wise LA; Laughlin-Tommaso SK; Diamond MP; Marsh EE; Jacoby VL; Anchan RM; Venable S; Larry GM; Lytle B; Wang T; Myers ER
Fertil Steril; 2020 Mar; 113(3):618-626. PubMed ID: 32192594
[TBL] [Abstract][Full Text] [Related]
15. Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis.
You JH; Sahota DS; Yuen PM
Fertil Steril; 2009 Feb; 91(2):580-8. PubMed ID: 18295216
[TBL] [Abstract][Full Text] [Related]
16. The effect of a gynecologist-interventional radiologist relationship on selection of treatment modality for the patient with uterine myoma.
Zurawin RK; Fischer JH; Amir L
J Minim Invasive Gynecol; 2010; 17(2):214-21. PubMed ID: 20226411
[TBL] [Abstract][Full Text] [Related]
17. The incidence of hysterectomy, uterus-preserving procedures and recurrent treatment in the management of uterine fibroids.
Martín-Merino E; García Rodríguez LA; Wallander MA; Andersson S; Soriano-Gabarró M
Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():147-52. PubMed ID: 26407334
[TBL] [Abstract][Full Text] [Related]
18. Uterine Artery Embolization and Surgical Methods for the Treatment of Symptomatic Uterine Leiomyomas: A Systemic Review and Meta-analysis Followed by Indirect Treatment Comparison.
Fonseca MCM; Castro R; Machado M; Conte T; Girao MJBC
Clin Ther; 2017 Jul; 39(7):1438-1455.e2. PubMed ID: 28641997
[TBL] [Abstract][Full Text] [Related]
19. [Uterine artery embolization for myomas treatment].
Kahn V; Pelage JP; Marret H
Presse Med; 2013; 42(7-8):1127-32. PubMed ID: 23602353
[TBL] [Abstract][Full Text] [Related]
20. Payer costs in patients undergoing uterine artery embolization, hysterectomy, or myomectomy for treatment of uterine fibroids.
Dembek CJ; Pelletier EM; Isaacson KB; Spies JB
J Vasc Interv Radiol; 2007 Oct; 18(10):1207-13. PubMed ID: 17911509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
